bioRxiv (Cold Spring Harbor Laboratory),
Год журнала:
2023,
Номер
unknown
Опубликована: Июль 28, 2023
Neurological
impairment
is
the
most
common
finding
in
patients
with
post-acute
sequelae
of
COVID-19.
Furthermore,
survivors
pneumonia
from
any
cause
have
an
elevated
risk
dementia
BACKGROUNDSurvivors
of
pneumonia,
including
SARS-CoV-2
are
at
increased
risk
for
cognitive
dysfunction
and
dementia.
In
rodent
models,
following
pneumonia
has
been
linked
to
the
systemic
release
lung-derived
pro-inflammatory
cytokines.
Microglia
poised
respond
inflammatory
signals
from
circulation,
their
impairment
in
murine
models
dementia
humans.METHODSWe
measured
levels
55
cytokines
chemokines
bronchoalveolar
lavage
fluid
plasma
341
patients
with
respiratory
failure
13
healthy
controls,
93
unvaccinated
COVID-19
203
other
causes
pneumonia.
We
used
flow
cytometry
sort
neuroimmune
cells
postmortem
brain
tissue
5
who
died
3
single-cell
RNA-sequencing.RESULTSMicroglia
exhibited
a
transcriptomic
signature
suggestive
activation
by
circulating
Peak
were
similar
irrespective
etiology,
but
cumulative
cytokine
exposure
was
higher
COVID-19.
Treatment
corticosteroids
reduced
expression
COVID-19-specific
cytokines.CONCLUSIONProlonged
lung
inflammation
results
sustained
elevations
compared
those
secondary
pathogens.
exhibit
transcriptional
responses
These
findings
support
data
causally
linking
further
investigation
into
role
microglia
pneumonia-related
dysfunction.FUNDINGSCRIPT
U19AI135964,
UL1TR001422,
P01AG049665,
P01HL154998,
R01HL149883,
R01LM013337,
R01HL153122,
R01HL147290,
R01HL147575,
R01HL158139,
R01ES034350,
R01ES027574,
I01CX001777,
U01TR003528,
R21AG075423,
T32AG020506,
F31AG071225,
T32HL076139.
Timely
access
to
specialist
care
is
crucial
in
expeditious
diagnosis
and
treatment.
Our
study
aimed
assess
the
time
patients
wait
from
being
referred
by
a
physician
seeing
neurologist
using
Medicare
data.
Specifically,
we
evaluated
differences
related
sex,
race/ethnicity,
geography,
availability
of
neurologists.
We
conducted
cross-sectional
analysis
2018-2019
sample
who
had
new
patient
visit
neurologist.
primary
outcome
was
between
their
last
with
referring
first
(the
index
visit).
also
looked
at
for
neurologic
condition
that
same
condition.
used
linear
mixed-effects
model
identify
factors
associated
time,
considering
patients'
hospital
referral
regions
(HRRs).
identified
163,313
beneficiaries
after
them.
Their
average
age
73.8
(SD
10.7).
The
median
(interquartile
range)
34
days
(15-70),
18%
waited
>90
days.
Patients
multiple
sclerosis
(MS)
an
29.4
longer,
epilepsy
10.4
Parkinson
disease
(PD)
9.3
longer
than
back
pain.
There
were
no
significant
times
across
race/ethnicity
sex.
showed
varying
levels
availability.
When
visited
located
outside
residential
or
physician's
HRR,
extended
11
found
that,
see
them
while
more
90
Factors
such
as
did
not
significantly
affect
timely
MS,
epilepsy,
PD
times,
despite
needing
specialized
neurologists
can
provide.
This
highlights
need
innovative
approaches
improve
Annals of Neurology,
Год журнала:
2024,
Номер
unknown
Опубликована: Ноя. 22, 2024
Objective
To
investigate
neurologic
manifestations
of
post‐acute
sequelae
SARS‐CoV‐2
infection
(Neuro‐PASC)
in
post‐hospitalization
Neuro‐PASC
(PNP)
and
non‐hospitalized
(NNP)
patients
across
the
adult
lifespan.
Methods
Cross‐sectional
study
first
consecutive
200
PNP
1,100
NNP
evaluated
at
a
Neuro‐coronavirus
disease
2019
(COVID‐19)
clinic
between
May
2020
March
2023.
Patients
were
divided
into
younger
(18–44
years),
middle‐age
(45–64
older
(65+
years)
age
groups.
Results
Younger
individuals
accounted
for
142
(71%)
995
1100
(90.5%)
patients.
Significant
age‐related
differences
frequencies
comorbidities
abnormal
findings
demonstrated
higher
prevalence
Conversely,
10
months
from
COVID‐19
onset,
we
found
significant
symptoms
indicating
lower
prevalence,
therefore,
symptom
burden,
individuals.
Moreover,
there
subjective
impression
fatigue
(median
[interquartile
range
(IQR)]
patient‐reported
outcomes
measurement
information
system
[PROMIS]
score:
64
[57–69],
63
[57–68],
60.5
[50.8–68.3];
p
=
0.04)
sleep
disturbance
[IQR]
PROMIS
57
[51–63],
56
[53–63],
54
[46.8–58];
0.002)
group,
commensurate
with
impairment
quality
life
(QoL)
among
Finally,
objective
executive
function
National
Institutes
Health
[NIH]
toolbox
48
[35–63],
49
[38–63],
54.5
[45–66.3];
0.01),
working
memory
NIH
47
[40–53],
50
[44–57],
[43–58];
0.0002)
patients,
worst
performance
coming
group.
Interpretation
are
disproportionally
affected
by
regardless
acute
severity.
Although
people
more
frequently
have
comorbidities,
suffer
burden
cognitive
dysfunction
contributing
to
decreased
QoL.
principally
affects
adults
their
prime,
profound
public
health
socioeconomic
impacts
warranting
dedicated
resources
prevention,
diagnosis
interventions.
ANN
NEUROL
2024